All News

RA erosions bone ACR

AI Identifies and Predicts Radiographic Change in Rheumatoid Arthritis

d ACR

The American College of Rheumatology's (ACR) has published a preview of new research from ACR Convergence 2023 showing that AI and a deep learning system could accurately identify and predict joint space narrowing and erosions in hand radiographs of patients with rheumatoid arthritis (RA).

Read Article
Xray.hand__0.jpg

X-Rays Questioned for Diagnosing Early Rheumatoid Arthritis

d MedPage Today

Routine hand and foot radiographs in more than 700 patients being evaluated for rheumatoid arthritis (RA) made almost no difference in diagnosing the condition nor in predicting its course, Dutch researchers said.

Read Article
bone.infection.gram_.rod_.jpg

Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee Arthroplasty

d Jack Cush, MD

A study of nearly 80,000 US veterans who underwent primary knee joint arthroplasty (TKA) showed  the incidence of prosthetic joint infection (PJI) was highest in the first 3 months and remained elevated through 12 months compared with 12 months or more after surgery.

Read Article
price%20of%20pills.jpg

ACR Reacts to 2024 Medicare Physician Fee Schedule

d ACR

The American College of Rheumatology (ACR) expressed concern that the conversion factor included in the Centers for Medicare and Medicaid Services (CMS) CY 2024 Medicare Physician Fee Schedule and Quality Payment Program final rule is insufficient to address rising inflation.

Read Article
genes_0.jpg

Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants

d Jack Cush, MD

A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions.

Read Article
QD Clinics - Neighbor Consults Your neighbor has a Swollen RPIP4. QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego https://t.co/ZXNalfiVFv https://t.co/TAxpVyowF5

Links:

Dr. John Cush RheumNow ( View Tweet)
Patients Don't Read Textbooks RA patient unresponsive to biologics, now has enthesitis; what to do? QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego https://t.co/hlacYXm0Nh https://t.co/52Xy3E8kXi

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Reacts to 2024 Medicare Physician Fee Schedule The ACR expressed concern that the conversion factor included in the CMS CY 2024 Medicare Physician Fee Schedule and Quality Payment Program final rule is insufficient to address rising inflation https://t.co/ZkMdqJEOkm https://t.co/70SxSGckGf

Links:

Dr. John Cush RheumNow ( View Tweet)
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions. https://t.co/MRFwrCXIlQ https://t.co/Su3nMs4CNW

Links:

Dr. John Cush RheumNow ( View Tweet)
2023 Medscaped Female Compensation Survey asked What percentage would again chose their specialty ? Top 5 specialties rechosen: Cardiology: 82% & Dermatology: 82% Psychiatry: 81% Allergy and immunology: 80% Neurology: 79% Rheumatology: 78% https://t.co/Zy4AJzb7dn. https://t.co/m9HjQ4T5aW

Links:

Dr. John Cush RheumNow ( View Tweet)
Long term results of the MAINRITSAN study (Maintenance Remission w/ RTX in Systemic AAV) showed fixed-schedule RTX superior to AZA in preventing major relapses at 84mos (HR 0.38), but tailored-RTX assoc w/ incr risk of major relapse (HR 2.92) https://t.co/xLxvPCsRC9 https://t.co/mWwo7GgCIq

Links:

Dr. John Cush RheumNow ( View Tweet)
Biologics, #RA and Risk of skin CA (NMSC) is complex. - RA alone is a risk for NMSC 49K study of ABA & NMSC ; - In RCTs, risk same w/ ABA & PBO - Registries & Claims data: equal w/ ABA, csDMARDs. b/tsDMARDs - Pooled obs data shows slight ABA risk https://t.co/tp6F0cJWug https://t.co/u6UdAUZqoc

Links:

Dr. John Cush RheumNow ( View Tweet)
UK biobank population study shows a bidirectional assoc. betw RA & ILD (each @ incr risk for the other). In non-COPD pts, RA increased risk of COPD (HR=1.65) & in non-RA pts, COPD had a higher risk of future RA (HR=1.67). Both mediated by inflammation https://t.co/imn4ddV7CS https://t.co/UZaszEnCqt

Links:

Dr. John Cush RheumNow ( View Tweet)
Good Treatment review of biologics (IL-1, IL-6) in systemic JIA (Stills) including complications of #MAS and lung disease; also info on horizon therapies like JAK inhibitors and IL-18 targeting and novel biomarkers (calgranulins, IL-18 and CXCL9) https://t.co/ACe7nDDwop https://t.co/lV66WerkAp

Links:

Dr. John Cush RheumNow ( View Tweet)
PMR QD Clinics - Teaching Cases https://t.co/fJThsc2T2k https://t.co/c4mAVqfBeO

Links:

Dr. John Cush RheumNow ( View Tweet)
Late Should Not Be Less Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past week on RheumNow . https://t.co/GwJdJKHuDZ https://t.co/S51g7aQ0i4

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow will be providing #ACR23 coverage from Nov 11-15. Tune in for daily recaps, KOL videos, live streaming and more. https://t.co/2kBkHq6rIc
Dr. John Cush RheumNow ( View Tweet)
LANCET: Efgartigimod (neonatal Fc receptor mAb) shown effective in chronic #ITP. RCT, 205 pts with refractory ITP (Plt <30K for ~10.6 yrs) Rx w/ EFGR vs PBO. @24 wks EFGR incr Plt >50k in 22% vs. 6%). A larger RCT in progress https://t.co/uXyjYoXlyF https://t.co/jGroGNeD4W

Links:

Dr. John Cush RheumNow ( View Tweet)
Marijuana use is on the rise, including older adults. Data presented at 2023 AHA (cardiology) meeting suggests that marijuana user have higher risk of MI & CVA; & daily marijuana users were 34% more likely to develop heart failure (in hospitalized adults) https://t.co/EnEnf6pqdr https://t.co/GXSv30AFLr

Links:

Dr. John Cush RheumNow ( View Tweet)
NEJM: Clinical Examination of the Cervical Spine (full read, with video). Great overview of Cx exam, useful in evaluation of axial neck pain, radiculopathy, or myelopathy; info on dermatomes, reflexes, Lhermites sign, etc https://t.co/EMizgh6Dtg https://t.co/6tdx1LBSDh

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×